Central-Line–Associated Bloodstream Infection Caused by <i>Sporobolomyces salmonicolor</i>

Tang, Hung‐Jen; Lai, Chih‐Cheng; Chao, Chien‐Ming

doi:10.1017/ice.2015.158

Cited by 6 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The rest 12 patients occupying 24.5% of the infected individuals were reported to have secondary bloodstream infection. Type of central line was not seen to be associated with the development of Central Line Associated Bloodstream Infection (CLABSI) Tang et al (2015).…”

Section: Resultsmentioning

confidence: 98%

A Comprehensive Update on Incidence, Prevalence and Complex Etiology of Central Line–associated Bloodstream Infection in Pediatric Intensive Care Units in King Saud Medical City

Abdulrahiem

Sultan

Alaklobi

et al. 2021

Int. J. Res. Granthaalayah

View full text Add to dashboard Cite

Central Line Associated Bloodstream Infection (CLABSI) is a type of bloodstream infection that is caused by microorganisms after the insertion of central lines. Paediatric Intensive Care Units have been studied to conduct this research on CLABSI in children from 2 to 15 years old. Children have been divided in two age groups that are 2-5 and 5-15 years. The Royal Children’s Hospital, Melbourne has been chosen as a sample of this besides other five hospitals of Australia. A total of 350 patients are studied in the course of this research and 216 among them were inserted with central lines. Bloodstream infection has been identified in 49 patients from these 216 patients and CLABSI occurred in 75.51% of them that is 37 patients. Associated microorganisms and other underlying diseases are listed in this study to develop an idea about factors responsible for CLABSI.

show abstract

Section: Resultsmentioning

confidence: 98%

A Comprehensive Update on Incidence, Prevalence and Complex Etiology of Central Line–associated Bloodstream Infection in Pediatric Intensive Care Units in King Saud Medical City

Abdulrahiem

Sultan

Alaklobi

et al. 2021

Int. J. Res. Granthaalayah

View full text Add to dashboard Cite

show abstract

“…As it has also not yet been isolated in the human digestive tract, gastro-intestinal translocation is presented as a probable source of infection [57]. Another rare fungus, Sporobolomyces salmonicolor, stands out for its isolation being limited solely to deep sites with systemic involvement, endophthalmitis-like ocular involvement, and two meningitislike central nervous system involvements [58][59][60][61][62]. Likewise, the only reported isolation of Sporobolomyces roseus was from the cerebrospinal fluid of a patient with meningitis [63].…”

Section: Othersmentioning

confidence: 99%

A Repertoire of the Less Common Clinical Yeasts

Menu,

Filori,

Dufour

et al. 2023

JoF

View full text Add to dashboard Cite

Invasive fungal diseases are a public health problem. They affect a constantly increasing number of at-risk patients, and their incidence has risen in recent years. These opportunistic infections are mainly due to Candida sp. but less common or rare yeast infections should not be underestimated. These so-called “less common” yeasts include Ascomycota of the genera Candida (excluding the five major Candida species), Magnusiomyces/Saprochaete, Malassezia, and Saccharomyces, and Basidiomycota of the genera Cryptococcus (excluding the Cryptococcus neoformans/gattii complex members), Rhodotorula, and Trichosporon. The aim of this review is to (i) inventory the less common yeasts isolated in humans, (ii) provide details regarding the specific anatomical locations where they have been detected and the clinical characteristics of the resulting infections, and (iii) provide an update on yeast taxonomy. Of the total of 239,890 fungal taxa and their associated synonyms sourced from the MycoBank and NCBI Taxonomy databases, we successfully identified 192 yeasts, including 127 Ascomycota and 65 Basidiomycota. This repertoire allows us to highlight rare yeasts and their tropism for certain anatomical sites and will provide an additional tool for diagnostic management.

show abstract

“…5,172,197 Local antifungal prophylactic strategies may increase the risk of nosocomial rare yeast infections by exerting excessive selective pressure. 5,155,165,166,177,[183][184][185][186][187]193,214 Several small, though important, nosocomial outbreaks are reported in the literature. A recent outbreak of Dirkmeia churashimaensis (previously Pseudozyma churashimaensis) in 12 premature neonates in a subspecialty hospital in Delhi, India, over 6 months, resulted in 5 deaths (42%), without an environmental source identified.…”

Section: Recommendationsmentioning

confidence: 99%

“…5,143,149,166,171,175,177,[183][184][185][206][207][208][209] Patients at particularly high risk include those with haematological malignancies, post-haemopoietic stem cell transplantation, prolonged neutropenia, complex intra-abdominal pathology, SOT recipients and pre-term infants in neonatal ICU. 5,143,149,150,166,171,173,175,177,[183][184][185][186][187]193,195,[206][207][208][209][210] Rare yeast fungaemia can result in endovascular infections, chiefly infective endocarditis, in addition to the seeding of virtually any organ, particularly the skin, liver, spleen, brain and lungs. 5,143,149,166,171,175,177,[183][184][185][206]…”

Section: Recommendationsmentioning

confidence: 99%

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Hall

Cooper

Grigoriadis

et al. 2021

Internal Medicine Journal

View full text Add to dashboard Cite

Cryptococcosis caused by the Cryptococcus neoformans-Cryptococcus gattii complex is an important opportunistic infection in people with immunodeficiency, including in the haematology/oncology setting. This may manifest clinically as cryptococcal meningitis or pulmonary cryptococcosis, or be detected incidentally by cryptococcal antigenemia, a positive sputum culture or radiological imaging. Non-Candida, non-Cryptococcus spp. rare yeast fungaemia are increasingly common in this population. These consensus guidelines aim to provide clinicians working in the Australian and New Zealand haematology/oncology setting with clear guiding principles and practical recommendations for the management of cryptococcosis, while also highlighting important and emerging rare yeast infections and their recommended management.

show abstract

Central-Line–Associated Bloodstream Infection Caused by Sporobolomyces salmonicolor

Cited by 6 publications

References 7 publications

A Comprehensive Update on Incidence, Prevalence and Complex Etiology of Central Line–associated Bloodstream Infection in Pediatric Intensive Care Units in King Saud Medical City

A Comprehensive Update on Incidence, Prevalence and Complex Etiology of Central Line–associated Bloodstream Infection in Pediatric Intensive Care Units in King Saud Medical City

A Repertoire of the Less Common Clinical Yeasts

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Contact Info

Product

Resources

About